Guerra Advisors’s Atossa Therapeutics ATOS Stock Holding History

Guerra Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-683	Closed	-$8.51K	–	931
2025 Q2	$8.51K	Buy	+683	New	+$8.16K	﹤0.01%	72

Other funds holding ATOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Guerra Advisors's ATOS Position: Q3 2025 in Review

Guerra Advisors sold out of Atossa Therapeutics (ATOS) in Q3 2025, closing a stake of 683 shares — an estimated $8.51K sold.

Guerra Advisors first reported a position in ATOS in Q2 2025 and held it in 1 quarter. The position peaked at $8.51K in Q2 2025. 66 funds tracked by Wall St. Rank hold ATOS as of Q3 2025.

Guerra Advisors reported no remaining Atossa Therapeutics position as of Q3 2025 after selling out during the quarter.
Guerra Advisors sold 683 Atossa Therapeutics shares in Q3 2025, an estimated $8.51K.
Guerra Advisors first reported a position in Atossa Therapeutics in Q2 2025 and held it in 1 quarter.
Guerra Advisors's Atossa Therapeutics position peaked at $8.51K in Q2 2025.
66 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.